---
document_datetime: 2023-09-21 19:39:18
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/palynziq-epar-all-authorised-presentation_en.pdf
document_name: palynziq-epar-all-authorised-presentation_en.pdf
version: success
processing_time: 0.3650075
conversion_datetime: 2025-12-20 01:48:10.294083
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## EU Number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

EU/1/19/1362/001 Palynziq 2.5 mg Solution for injection Subcutaneous use Pre-filled syringe (glass) 0.5 ml (5 mg/ml) 1 pre-filled syringe EU/1/19/1362/002 Palynziq 10 mg Solution for injection Subcutaneous use Pre-filled syringe (glass) 0.5 ml (20 mg/ml) 1 pre-filled syringe EU/1/19/1362/003 Palynziq 20 mg Solution for injection Subcutaneous use Pre-filled syringe (glass) 1 ml (20 mg/ml) 1 pre-filled syringe EU/1/19/1362/004 Palynziq 20 mg Solution for injection Subcutaneous use Pre-filled syringe (glass) 1 ml (20 mg/ml) 10 pre-filled syringes